The American Society of Hematology launches Blood journal app

April 19, 2012

(WASHINGTON, April 19, 2012) - The American Society of Hematology (ASH), the world's largest organization concerned with the causes and treatment of blood disorders, today released the Blood journal app for iPhone and iPad. Blood is the official Journal of the Society and the most cited peer-reviewed publication in the field.

By downloading the free application, users can access First Edition articles, conduct full-text searches, and view listings of articles by author and date with the in-app browser. The app also allows users to share articles via email and Twitter and download multiple issues on their devices and access them regardless of Internet connectivity, a feature not readily available on many other journal apps.

The launch of the Blood journal app is the latest technical innovation for the journal following recent reader preference research. Results from a 2011 readership survey indicate that nearly 20 percent of journal readers anticipate regularly accessing, searching, and reading professional journal literature on smartphones and tablets by 2015, signaling an opportunity for Blood to further expand its digital footprint.

"The launch of the Blood journal app demonstrates our recognition that our readers expect to be able to access journals on the go and our commitment to offering them the most cutting-edge science in the field through as many channels as possible," said Blood Editor-in-Chief Cynthia Dunbar, MD.

A version of the Blood journal app for Android devices will soon be available.

The Blood journal app was developed by Dartmouth Journal Services and The Sheridan Technology Group with support from a subcommittee of the following ASH members: At launch, ASH is offering a free 90-day trial of the Blood journal app to the general public. After 90 days, Blood subscriber or ASH member credentials will be required to continue to access full-text articles using the app. Abstracts will remain free to all users.

Visit the Blood journal website for complete download instructions and a direct link to the download in the iTunes App Store.
-end-
About Blood
Blood, the official journal of the American Society of Hematology, has been in continuous publication since 1946. With 1,364 articles published annually, an impact factor of 10.558, and an Immediacy Index of 1.980, Blood is the most cited peer-reviewed publication in the field. It provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology.

About the American Society of Hematology (ASH)
The American Society of Hematology is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology. The official journal of ASH is Blood, the most cited peer-reviewed publication in the field, which is available weekly in print and online.

American Society of Hematology

Related Hematology Articles from Brightsurf:

Study finds gender disparities in hematology research success
Hematologists who complete a mentored training program experience greater levels of academic success than those who do not; however, a study published today in Blood Advances suggests a slight discrepancy in success levels between male and female hematologists.

Survey suggests mentorship in medical school is vital to future of hematology
A survey of US hematology-oncology fellows suggests medical school plays an important role in shaping their interest in pursuing careers in hematology, particularly when students are exposed to hematology and oncology as part of core clerkships in internal medicine and pediatrics.

JAK inhibitors associated with aggressive lymphoma
Austrian researchers have discovered that a small number of patients taking targeted drugs known as Janus kinase (JAK) inhibitors to treat myelofibrosis may develop aggressive lymphomas.

For young adults with blood cancer, pediatric centers may improve survival
Adolescents and young adults with acute leukemia have a survival advantage if they receive treatment at a pediatric cancer center versus an adult center, according to a new study.

Global hematology diagnostics market estimated to expand at a robust CAGR over 2021
Hematology includes various IVD technologies such as blood analysis, flow cytometry, immunodiagnostics, molecular diagnostics, hemostasis, histology, and cytology.

Late-breaking hematology abstracts signal new, near-term therapeutic options for patients
In four clinical trials being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers report promising results suggesting patients with blood disorders and several types of cancer will soon have significantly expanded options for treatment.

American Society of Hematology announces top trainee abstracts of 2016 ASH Annual Meeting
The American Society of Hematology (ASH) is pleased to recognize the following trainees with the highest-scoring abstracts in the categories of undergraduate student, medical student, graduate student, resident physician, and postdoctoral fellow at the 58th ASH Annual Meeting Dec.

ASH to expand family of blood journals with launch of new cutting-edge publication
The American Society of Hematology (ASH) will launch an open-access journal to complement Blood, its flagship publication and the most-cited journal in hematology.

Study finds common genetic variants that double risk for blood clots in African Americans
New research published online today in Blood the Journal of the American Society of Hematology, identifies common genetic variants predominantly found in African Americans that double their risk for blood clots.

Mount Sinai researchers present results at American Society of Hematology Meeting
Icahn School of Medicine at Mount Sinai researchers will present several landmark studies at the 2015 American Society of Hematology meeting Dec.

Read More: Hematology News and Hematology Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.